 "Sun Pharma shares drop over 3% on disappointing earnings in Jul-Sep quarter")
New Delhi: Shares of Sun Pharmaceutical Industries on Wednesday fell by over 3 percent after the company reported a 59.19 percent decline in consolidated net profit for the September quarter.
The stock slipped 3.29 percent to Rs 508.80 on the BSE.
At the NSE, it fell 3.32 percent to Rs 508.55.
Pharma major Sun Pharmaceutical Industries on Tuesday reported a 59.19 percent drop in consolidated net profit to Rs 912.12 crore for the September quarter, mainly on account of degrowth in the US sales.
The company had posted a net profit of Rs 2,235.14 crore for the corresponding period of the previous fiscal, Sun Pharma said in a BSE filing.
Consolidated total revenue from operations stood at Rs 6,650.34 crore. It was Rs 8,260.11 crore in the same period of the previous year.
 "Is India planning to tax Netflix's operations in the country?")
 "GST revenue likely to be around Rs 1.45 crore in September")
 "PVR reports Q4 net loss of Rs 105.49 crore, revenue at Rs 537.14 crore")
 "Global factors, macro data, earnings to drive market trends this week, say analysts")
 "Is India planning to tax Netflix's operations in the country?")
 "GST revenue likely to be around Rs 1.45 crore in September")
 "PVR reports Q4 net loss of Rs 105.49 crore, revenue at Rs 537.14 crore")
 "Global factors, macro data, earnings to drive market trends this week, say analysts")